24-hour Serial Spirometric Assessment of Once-Daily Fluticasone furoate/Umeclidinium/Vilanterol Versus Twice-Daily Budesonide/Formoterol in Patients with COPD: Analysis of the FULFIL Study

figure

posted on 2020-09-28, 10:22 authored by David A Lipson, Ruby Birk, Noushin Brealey, Chang-Qing Zhu

The above Summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

Funding

GlaxoSmithKline

History

Usage metrics

Keywords

Chronic obstructive pulmonary disease Lung function Single-inhaler triple therapy Long-acting β2-agonist Long-acting muscarinic antagonist Inhaled corticosteroid Serial FEV1

Licence

CC BY-NC 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM